Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Fox

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 14, 2017
Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic sclerodermaKim M Hutchings, Erika M Lisabeth, Walajapet Rajeswaran, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2024
Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cellsMikel Gurrea-Rubio, Qi Wu, M Asif Amin, et al.
Blood|December 24, 2013
Plasma CXCL9 elevations correlate with chronic GVHD diagnosisCarrie L Kitko, John E Levine, Barry E Storer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 23, 2019
Georgia Abortion Law and Our Commitment to PatientsJoseph E Craft, Mary K Crow, Michael D Lockshin, et al.
Arthritis Research & Therapy|August 29, 2014
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeuticsGlynn Dennis, Cécile T J Holweg, Sarah K Kummerfeld, et al.
Research Square|October 27, 2023
Activation of Cytotoxic Lymphocytes Through CD6 Enhances Killing of Cancer CellsMikel Gurrea-Rubio, Qi Wu, M Asif Amin, et al.
JCI Insight|January 26, 2021
CD6 is a target for cancer immunotherapyJeffrey H Ruth, Mikel Gurrea-Rubio, Kalana S Athukorala, et al.
JCI Insight|March 29, 2022
Inhibition of bromodomain extraterminal histone readers alleviates skin fibrosis in experimental models of sclerodermaSirapa Vichaikul, Mikel Gurrea-Rubio, M Asif Amin, et al.
Nature Communications|February 7, 2017
DEK-targeting DNA aptamers as therapeutics for inflammatory arthritisNirit Mor-Vaknin, Anjan Saha, Maureen Legendre, et al.
Cell Reports. Medicine|July 25, 2023
An agonistic anti-signal regulatory protein α antibody for chronic inflammatory diseasesMarkus M Xie, Bingbing Dai, Jason A Hackney, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry Letters|March 14, 2017
Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic sclerodermaKim M Hutchings, Erika M Lisabeth, Walajapet Rajeswaran, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2024
Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cellsMikel Gurrea-Rubio, Qi Wu, M Asif Amin, et al.
Blood|December 24, 2013
Plasma CXCL9 elevations correlate with chronic GVHD diagnosisCarrie L Kitko, John E Levine, Barry E Storer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 23, 2019
Georgia Abortion Law and Our Commitment to PatientsJoseph E Craft, Mary K Crow, Michael D Lockshin, et al.
Arthritis Research & Therapy|August 29, 2014
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeuticsGlynn Dennis, Cécile T J Holweg, Sarah K Kummerfeld, et al.
Research Square|October 27, 2023
Activation of Cytotoxic Lymphocytes Through CD6 Enhances Killing of Cancer CellsMikel Gurrea-Rubio, Qi Wu, M Asif Amin, et al.
JCI Insight|January 26, 2021
CD6 is a target for cancer immunotherapyJeffrey H Ruth, Mikel Gurrea-Rubio, Kalana S Athukorala, et al.
JCI Insight|March 29, 2022
Inhibition of bromodomain extraterminal histone readers alleviates skin fibrosis in experimental models of sclerodermaSirapa Vichaikul, Mikel Gurrea-Rubio, M Asif Amin, et al.
Nature Communications|February 7, 2017
DEK-targeting DNA aptamers as therapeutics for inflammatory arthritisNirit Mor-Vaknin, Anjan Saha, Maureen Legendre, et al.
Cell Reports. Medicine|July 25, 2023
An agonistic anti-signal regulatory protein α antibody for chronic inflammatory diseasesMarkus M Xie, Bingbing Dai, Jason A Hackney, et al.
Pageof 16